Voyageur Pharmaceuticals (CVE:VM) Stock Price Up 47.4% – Still a Buy?
by Mitch Edgeman · The Markets DailyShares of Voyageur Pharmaceuticals Ltd. (CVE:VM – Get Free Report) shot up 47.4% during trading on Saturday . The company traded as high as C$0.14 and last traded at C$0.14. 1,312,210 shares were traded during trading, an increase of 427% from the average session volume of 249,010 shares. The stock had previously closed at C$0.10.
Voyageur Pharmaceuticals Price Performance
The company has a current ratio of 0.17, a quick ratio of 0.84 and a debt-to-equity ratio of 3.21. The stock has a market cap of C$19.53 million, a P/E ratio of -14.00 and a beta of 0.32. The business has a 50-day simple moving average of C$0.07 and a 200 day simple moving average of C$0.06.
About Voyageur Pharmaceuticals
Voyageur Pharmaceuticals Ltd., together with its subsidiaries, engages in the acquiring, exploring, and developing raw materials for pharmaceutical products, primarily in the province of British Columbia, Canada, and the state of Utah. The company develops barium and iodine-based APIs. The company was formerly known as Voyageur Minerals Ltd.
Featured Articles
- Five stocks we like better than Voyageur Pharmaceuticals
- How Technical Indicators Can Help You Find Oversold Stocks
- Driving Forward: Lucid’s Growing Sales and Gravity SUV’s Impact
- What is the Euro STOXX 50 Index?
- Why Amazon’s Next Earnings Could Trigger a Stock Breakout
- Bank Stocks – Best Bank Stocks to Invest In
- With This Kind of Data, The Fed Isn’t Cutting Rates This Year